Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Age: Not specified

Healthy Volunteers:

This study is NOT accepting healthy volunteers

Inclusion Criteria:

* Received a regimen containing one or more immuno-oncology therapeutics * Must have experienced one or more of the following: * One or more serious (Grade 3-4) AEs that are likely immune-related * One or more Grade 2 dermatologic or rheumatologic AEs that are likely immune-related * Diagnosis of a rare infection, e.g., fungal or mycobacterial, after starting IO treatment \*\* Note: Diagnosis of SARS-CoV-2 (COVID-19) is excluded * Hyperprogression. Image submission for patients experiencing hyperprogression is required. For assistance in determining hyperprogression for purposes of eligibility, institutions may contact the study chair and submit images for central review * Has not previously been registered to this study

Interventions:

PROCEDURE: Biospecimen Collection, OTHER: Medical Chart Review

Conditions:

Malignancy

Contact(s): David Kozono, MD, PhD - dkozono@bwh.harvard.edu

Principal Investigator:

Phase:

IRB Number:

System ID: NCT04242095

See this study on ClinicalTrials.gov

Thank you for choosing StudyFinder. Please visit http://studyfinder.cctr.vcu.edu to find a Study which is right for you and contact ctrrecruit@vcu.edu if you have questions or need assistance.

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Email this study information to me

Contact the study team